Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine

被引:42
|
作者
Koong, Lin Ru [1 ]
Chee, Wai Kitt [1 ]
Toh, Zhi Hong [1 ]
Ng, Xin Le [1 ]
Agrawal, Rupesh [1 ,2 ,3 ,4 ]
Ho, Su Ling [1 ]
机构
[1] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore 308433, Singapore
[2] Lee Kong Chian Sch Med, Singapore, Singapore
[3] Singapore Eye Res Inst, Ocular Infect & AntiMicrobials, Singapore, Singapore
[4] Duke NUS Med Sch, Acad & Clin Programme, Ophthalmol & Visual Sci, Singapore, Singapore
关键词
COVID-19; vaccine; VKH disease; PfizerBioNtech; vaccine side effects; exudative retinal detachment;
D O I
10.1080/09273948.2021.1974492
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.
引用
收藏
页码:1212 / 1215
页数:4
相关论文
共 50 条
  • [31] Vogt-Koyanagi-Harada Disease Associated with Rheumatoid Arthritis
    Tufan, Hasan Ali
    Akbal, Ayla
    Arikan, Sedat
    Gencer, Baran
    Kara, Selcuk
    Tufan, Abdurrahman
    TURKISH JOURNAL OF RHEUMATOLOGY, 2013, 28 (03) : 212 - 215
  • [32] Tofacitinib in Vogt-Koyanagi-Harada disease
    Majumder, Parthopratim Dutta
    Shah, Amravi
    Kaushik, Viswanath
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (09) : 1938 - 1939
  • [33] Vogt-Koyanagi-Harada disease in children
    Abu El-Asrar, A. M.
    Al-Kharashi, A. S.
    Aldibhi, H.
    Al-Fraykh, H.
    Kangave, D.
    EYE, 2008, 22 (09) : 1124 - 1131
  • [34] Vogt-Koyanagi-Harada disease associated with brainstem encephalitis
    Hashimoto, Takao
    Takizawa, Hotake
    Yukimura, Kimie
    Ohta, Kouichi
    JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (04) : 593 - 595
  • [35] Electroretinogram changes associated with Vogt-Koyanagi-Harada disease
    Chu, DS
    Agriantonis, DJ
    Roy, MS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [36] Vogt-Koyanagi-Harada disease in children
    A M Abu El-Asrar
    A S Al-Kharashi
    H Aldibhi
    H Al-Fraykh
    D Kangave
    Eye, 2008, 22 : 1124 - 1131
  • [37] Pathology of Vogt-Koyanagi-Harada disease
    Rao N.A.
    International Ophthalmology, 2007, 27 (2-3) : 81 - 85
  • [38] HLA AND VOGT-KOYANAGI-HARADA DISEASE
    OHNO, S
    ACTA OPHTHALMOLOGICA, 1984, : 46 - 49
  • [39] Treatment of Vogt-Koyanagi-Harada Disease
    Alaql, Musab K.
    Akinfe, Akinwale A.
    AlNour, Mohammed K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (07)
  • [40] Vogt-Koyanagi-Harada disease in Spain
    Arriola-Villalobos, Pedro
    Moll-Udina, Aina
    Carrasco-Lopez-Brea, Mario
    Sacristan, Cristina
    Jose Capella, Maria
    Peiteado, Diana
    Garrote-Llorden, Ana
    Albert Fort, Mara
    Jodar Marquez, Margarita
    Gonzalez Guijarro, Juan Jacobo
    Demetrio-Pablo, Rosalia
    Sanchez Sevilla, Juan Luis
    Carreno, Ester
    Gonzalez-Lopez, Julio
    Miguel-Escuder, Lucia
    Cuadros, Carlos
    Diaz-Valle, David
    Adan, Alfredo
    Benitez del Castillo, Jose M.
    Fonollosa, Alejandro
    Cordero, Miguel
    Martinez Costa, Lucia
    Blanco-Alonso, Ricardo
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (03) : 1547 - 1554